1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Angioedema Treatment Market
2.2. Global Angioedema Treatment Market, By Treatment, 2023 (US$ Million)
2.3. Global Angioedema Treatment Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Angioedema Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Angioedema Treatment Market Vendors
3.2. Strategies Adopted by Angioedema Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Angioedema Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Angioedema Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Antihistamines
5.3.2. Cortecosteroids
5.3.3. Autoimmune Drugs
5.3.4. Antifibrinolytic Agents
5.3.5. Blood Protein Controllers


6. North America Angioedema Treatment Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
6.3.Angioedema Treatment Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)

7. UK and European Union Angioedema Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.Angioedema Treatment Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)

8. Asia Pacific Angioedema Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.Angioedema Treatment Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)

9. Latin America Angioedema Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
9.3.Angioedema Treatment Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)

10. Middle East and Africa Angioedema Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
10.3.Angioedema Treatment Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Angioedema Treatment Market: By Treatment, 2022-2032, USD (Million)

11. Company Profile
11.1. AstraZeneca plc
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. F. Hoffmann-La Roche AG
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Valeant Pharmaceuticals International.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Merck & Co.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Dyax Corp
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. CSL Behring
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Pharming Group
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. ViroPharma
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Other Notable Players
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives